Furio Maggiorotto

Candiolo, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.

Journal: ESMO open
Published: July 21, 2020

Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience.

Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience.

Journal: Cancers
Published: July 13, 2020

Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).

Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).

Journal: Gynecologic oncology
Published: July 12, 2020

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers.

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers.

Journal: Journal of ovarian research
Published: February 25, 2020

Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal.

Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal.

Journal: Breast (Edinburgh, Scotland)
Published: February 06, 2020

A retrospective analysis on 197 cases of breast cancer local recurrence: Biology, treatment, and prognosis.

A retrospective analysis on 197 cases of breast cancer local recurrence: Biology, treatment, and prognosis.

Journal: The breast journal
Published: October 07, 2019

Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome.

Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome.

Journal: Journal of clinical medicine
Published: December 31, 2018

TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers.

TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers.

Journal: Journal of ovarian research
Published: August 25, 2018

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.

Journal: Journal of ovarian research
Published: February 21, 2018

Feasibility and oncological safety of sentinel node biopsy in breast cancer patients with a local recurrence.

Feasibility and oncological safety of sentinel node biopsy in breast cancer patients with a local recurrence.

Journal: Breast (Edinburgh, Scotland)
Published: January 27, 2018

MRI to predict nipple-areola complex (NAC) involvement: An automatic method to compute the 3D distance between the NAC and tumor.

MRI to predict nipple-areola complex (NAC) involvement: An automatic method to compute the 3D distance between the NAC and tumor.

Journal: Journal of surgical oncology
Published: May 12, 2017

Primary tumor location predicts the site of local relapse after nipple-areola complex (NAC) sparing mastectomy.

Primary tumor location predicts the site of local relapse after nipple-areola complex (NAC) sparing mastectomy.

Journal: Breast cancer research and treatment
Published: January 07, 2017
Showing 1-12 of 25

Last Updated: 09/26/2026